Pathogenesis of the immunological deficiencies caused by infection with the human immunodeficiency virus

3-year suppression of HIV viremia with indinavir, zidovudine, and lamivudine.

Annals of internal medicine·2000

Phase I studies of hypericin, the active compound in St. John's Wort, as an antiretroviral agent in HIV-infected adults. AIDS Clinical Trials Group Protocols 150 and 258.

Annals of internal medicine·1999

Lymphocyte-proliferative responses to HIV antigens as a potential measure of immunological reconstitution in HIV disease.

AIDS research and human retroviruses·1998

Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy.

The New England journal of medicine·1997

Effect of therapeutic immunization with recombinant gp160 HIV-1 vaccine on HIV-1 proviral DNA and plasma RNA: relationship to cellular immune responses.

Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association·1997

A randomized, placebo-controlled study of the immunogenicity of human immunodeficiency virus (HIV) rgp160 vaccine in HIV-infected subjects with > or = 400/mm3 CD4 T lymphocytes (AIDS Clinical Trials Group Protocol 137).

The Journal of infectious diseases·1996

Bone metastasis in cancer: from microenvironmental remodeling to precision therapy.

Seminars in oncology·2026

Early hepatic decompensation is associated with mortality in patients with HCC treated with atezolizumab plus bevacizumab or durvalumab plus tremelimumab.

Seminars in oncology·2026

Rhabdomyolysis resulting from the interaction of rosuvastatin and abiraterone: A case study.

Seminars in oncology·2026

NK3 subsets are linked to NK cell exhaustion and immunotherapy responsiveness in tumor.

Seminars in oncology·2026

Dual alexithymia: A relational framework for clinical communication in oncology.

Seminars in oncology·2026

SPIB as a context-specific regulator in cancer: from molecular mechanisms to clinical implications.

Seminars in oncology·2026

Toll-like receptors 7 and 8 as therapeutic targets for human diseases.

International immunology·2026

Self-Assembling Peptide-Adjuvant Conjugate (SaPAC) Platform for Precision Cancer Immunotherapy.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026

Optimizing antibody-dependent cellular phagocytosis for cancer immunotherapy: mechanisms, constraints, and therapeutic strategies.

Journal of advanced research·2026

Jianwei Shoutai Pills enhances maternal-fetal immune tolerance via regulatory T cell modulation to ameliorate uterine aging-associated early pregnancy loss.

Phytomedicine : international journal of phytotherapy and phytopharmacology·2026

IL-1 signaling in cancer-associated fibroblasts: shaping fibroblast heterogeneity, tumor immunity, and therapeutic resistance.

Seminars in immunology·2026

Inflammatory intensity and stimulus type induce distinct miRNA regulatory programs in bovine endometrial epithelial cells.

Theriogenology·2026

Related Experiment Videos

Pathogenesis of the immunological deficiencies caused by infection with the human immunodeficiency virus

Related Concept Videos

3-year suppression of HIV viremia with indinavir, zidovudine, and lamivudine.

Phase I studies of hypericin, the active compound in St. John's Wort, as an antiretroviral agent in HIV-infected adults. AIDS Clinical Trials Group Protocols 150 and 258.

Lymphocyte-proliferative responses to HIV antigens as a potential measure of immunological reconstitution in HIV disease.

Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy.

Effect of therapeutic immunization with recombinant gp160 HIV-1 vaccine on HIV-1 proviral DNA and plasma RNA: relationship to cellular immune responses.

A randomized, placebo-controlled study of the immunogenicity of human immunodeficiency virus (HIV) rgp160 vaccine in HIV-infected subjects with > or = 400/mm3 CD4 T lymphocytes (AIDS Clinical Trials Group Protocol 137).

Bone metastasis in cancer: from microenvironmental remodeling to precision therapy.

Early hepatic decompensation is associated with mortality in patients with HCC treated with atezolizumab plus bevacizumab or durvalumab plus tremelimumab.

Rhabdomyolysis resulting from the interaction of rosuvastatin and abiraterone: A case study.

NK3 subsets are linked to NK cell exhaustion and immunotherapy responsiveness in tumor.

Dual alexithymia: A relational framework for clinical communication in oncology.

SPIB as a context-specific regulator in cancer: from molecular mechanisms to clinical implications.

Toll-like receptors 7 and 8 as therapeutic targets for human diseases.

Self-Assembling Peptide-Adjuvant Conjugate (SaPAC) Platform for Precision Cancer Immunotherapy.

Optimizing antibody-dependent cellular phagocytosis for cancer immunotherapy: mechanisms, constraints, and therapeutic strategies.

Jianwei Shoutai Pills enhances maternal-fetal immune tolerance via regulatory T cell modulation to ameliorate uterine aging-associated early pregnancy loss.

IL-1 signaling in cancer-associated fibroblasts: shaping fibroblast heterogeneity, tumor immunity, and therapeutic resistance.

Inflammatory intensity and stimulus type induce distinct miRNA regulatory programs in bovine endometrial epithelial cells.

Related Experiment Videos

Pathogenesis of the immunological deficiencies caused by infection with the human immunodeficiency virus

Related Concept Videos

Related Articles